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Abstract
Background: Pulmonary rehabilitation programs have been shown to increase functional exercise
capacity and quality of life in COPD patients. However, following the completion of pulmonary
rehabilitation the benefits begin to decline unless the program is of longer duration or ongoing
maintenance exercise is followed. Therefore, the aim of this study is to determine if supervised,
weekly, hospital-based exercise compared to home exercise will maintain the benefits gained from
an eight-week pulmonary rehabilitation program in COPD subjects to twelve months.
Methods:  Following completion of an eight-week pulmonary rehabilitation program, COPD
subjects will be recruited and randomised (using concealed allocation in numbered envelopes) into
either the maintenance exercise group (supervised, weekly, hospital-based exercise) or the control
group (unsupervised home exercise) and followed for twelve months. Measurements will be taken
at baseline (post an eight-week pulmonary rehabilitation program), three, six and twelve months.
The exercise measurements will include two six-minute walk tests, two incremental shuttle walk
tests, and two endurance shuttle walk tests. Oxygen saturation, heart rate and dyspnoea will be
monitored during all these tests. Quality of life will be measured using the St George's Respiratory
Questionnaire and the Hospital Anxiety and Depression Scale. Participants will be excluded if they
require supplemental oxygen or have neurological or musculoskeletal co-morbidities that will
prevent them from exercising independently.
Discussion: Pulmonary rehabilitation plays an important part in the management of COPD and
the results from this study will help determine if supervised, weekly, hospital-based exercise can
successfully maintain functional exercise capacity and quality of life following an eight-week
pulmonary rehabilitation program in COPD subjects in Australia.
Background
Chronic Obstructive Pulmonary Disease (COPD) is the
fourth leading cause of death in Australian males, the
sixth leading cause of death in females [1] and resulted in
5000 deaths in 2003 [2]. COPD is a progressive, disabling
disease, which has a significant impact on the health care
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system [1,3]. Early diagnosis and management of COPD
is a priority of health care services throughout Australia.
Management of COPD involves optimising medical ther-
apy, commencing smoking cessation and participating in
pulmonary rehabilitation.
Pulmonary Rehabilitation is a multi-disciplinary
approach to the management of patients with respiratory
disease. The program is individually tailored to the needs
of the patient, combining exercise, self-management edu-
cation and psychosocial support [4]. Pulmonary rehabili-
tation has been shown to improve functional exercise
capacity, quality of life and dyspnoea, and to reduce hos-
pital admissions and length of stay [5].
Following pulmonary rehabilitation, benefits in terms of
functional exercise capacity and quality of life are main-
tained for up to nine months [6-8]. However, the benefits
appear to decline by twelve months [9] unless the pro-
gram is of longer duration [10] or involves ongoing main-
tenance exercise [11,12]. There is little evidence to support
the best method of maintaining these gains long-term and
the above studies differ in length and intensity of the exer-
cise programs. As the majority of pulmonary rehabilita-
tion programs in Australia are of eight weeks duration, it
is important to determine the best method of maintaining
functional exercise capacity and quality of life, twelve
months following an eight-week pulmonary rehabilita-
tion program.
The aim of the study is to determine if supervised, weekly
exercise following an eight-week pulmonary rehabilita-
tion program will maintain the benefits to twelve months.
Methods
Participants
This study will be a prospective, randomised controlled
trial in participants diagnosed with COPD. Participants
will be recruited consecutively on completion of an eight-
week pulmonary rehabilitation program and randomised
into either a maintenance exercise group (ME) or a control
group and followed for 12 months. Randomisation will
be by computerised random number generation in con-
cealed envelopes prepared by an investigator not involved
in subject testing or training. The chief investigator will
conduct both testing and training so will be aware of
group allocation.
Participants will be excluded if they have experienced an
exacerbation of COPD in the previous month, if they
require supplemental oxygen, or if they have co-morbidi-
ties such as severe cardiovascular, neurological or muscu-
loskeletal conditions that will prevent them performing
functional exercise tests. The flow of participants through
the study will reflect the recommendations from the Con-
solidated Standards of Reporting Trials (CONSORT) state-
ment [13], and is illustrated in Figure 1. Participants will
receive written and verbal information explaining the
study and written consent will be obtained from all sub-
jects. Ethics approval to conduct the study has been
obtained from the Ethics Committee of Sydney South
West Area Health Service (Eastern Zone). The study will
take place at Royal Prince Alfred Hospital (RPAH), Syd-
ney, Australia.
Interventions
Participants randomised to the ME group will attend hos-
pital-based pulmonary rehabilitation once a week for
supervised exercise training and will also be asked to fol-
low an unsupervised home exercise program on four
other days a week. The hospital-based program will be
individually designed and supervised by a qualified phys-
iotherapist and will consist of lower limb and upper limb
exercise (Table 1) similar to those that the subject per-
formed during the eight-week pulmonary rehabilitation
program. More specifically, the program will consist of a)
lower limb endurance training in which the participant
will perform 20 minutes of stationary cycling and 20 min-
utes of walking, b) lower limb strength training using
weight machines for the quadriceps and gluteal muscles,
c) upper limb endurance training which will consist of
arm cycle ergometry and unsupported arm exercises with
light weights [14], d) upper limb strength training using
weight machines for the latissimus dorsi and pectoralis
major/minor muscles. All strength-training exercises will
be performed in three sets of ten repetitions.
Participants randomised to the control group will follow
standard care and be asked to follow an unsupervised
home exercise program on five days per week which will
consist of 30 minutes of walking, unsupported arm exer-
cises [14] and lower limb strengthening exercises five days
per week (Table 1). The exercises will be explained and
illustrated in the home exercise booklet that all partici-
pants will have received during pulmonary rehabilitation.
Participants in the ME group will be asked to follow the
same home exercise program four days a week. Partici-
pants in the control group will not be contacted between
testing sessions. Participants in both the ME and control
groups will be asked to complete an exercise diary by tick-
ing boxes to indicate the exercises they complete.
Outcomes measures
All outcome measures will be recorded at baseline, three,
six and 12 months post pulmonary rehabilitation (Figure
2). The outcome measures are outlined below.
1. Functional exercise capacity will be measured by:BMC Pulmonary Medicine 2007, 7:7 http://www.biomedcentral.com/1471-2466/7/7
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a) Six-minute walk test (6MWT) [15]. This test measures
the distance a participant is able to walk in six minutes
and will be performed using a protocol standardised for
factors known to affect results e.g. instructions, encour-
agement, number of tests and type of track [15]. Partici-
pants will be asked to walk as far as they can in six
minutes, to do the best they can, and to cover as much
ground as possible. Every minute participants will be
made aware of the time and will be given standardised
encouragement e.g. "You are doing well – you have 5 min-
utes to go!" This will be alternated each minute with
"Keep up the good work – you have 4 minutes remain-
ing!" If participants need to stop they can do so, but will
be asked every 15 seconds to commence walking again
when they feel able.
b) Incremental shuttle walk test (ISWT) [8]. This test is an
incremental, progressive, symptom-limited test. The par-
ticipants will listen to instructions from an audio-tape [8].
They will be asked to walk along a ten-metre track turning
around two cones in time with beeps from the tape and to
continue until they indicate they need to stop or are una-
Flow of participants through the study Figure 1
Flow of participants through the study. PRP = pulmonary rehabilitation program; COPD = chronic obstructive pulmo-
nary disease; x/wk = times per week.
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ble to keep pace with the beeps. The total distance walked
will be recorded.
c) Endurance shuttle walk test (ESWT) [16]. This test is
similar to the ISWT in terms of track length and instruc-
tions from an audiotape, however, as it is a measure of
endurance the participant will be asked to walk at a con-
stant speed for as long as possible (maximum of 20 min-
utes) following a two minute warm up period. The speed
for the ESWT for each participant will be based on the
result of his/her ISWT, using the recommended equation
[16]. The distance walked during the test will be recorded.
Before and immediately after each walk test the following
measurements will be recorded a) oxygen saturation and
heart rate using a portable saturation monitor (RAD-5v
Masimo Corp, Irvine, CA, USA); b) dyspnoea using the
Borg Scale category ratio 0–10 scale [17]. The 6MWT,
ISWT and ESWT will be performed twice at each time
point to account for a learning effect [18]. Participants will
rest for at least 30 minutes between tests or until oxygen
saturation, dyspnoea and heart rate return to resting lev-
els. The better distance walked in each test will be
recorded for analysis. Testing will be completed over a
two-day period at each time point.
2. Quality of life will be measured by:
a) St George's Respiratory Questionnaire (SGRQ) [19].
This is a disease specific, questionnaire shown to be sensi-
Table 1: Components of the exercise programs
Supervised Unsupervised
Equipment Yes No
Intensity Dyspnoea 3–4 Borg Scale Dyspnoea 3–4 Borg Scale
Duration 20 mins W
20 mins SC
30 mins AC, LWM, AWM, UAE
30 mins W
30 mins S, Sq, S/S, UAE
Total duration 70 mins 60 mins
Frequency
(per wk)
1 4 (ME group)
5 (Control group)
Venue Hospital gym Home
AC = arm crank ergometer; AWM = arm weight machine; LWM = leg weight machine; ME = maintenance exercise; mins = minutes; SC = 
stationary cycle; S = step-ups; Sq = wall squats; S/S = sit to stand exercises; UAE = upper limb unsupported arm exercises as described by Ries [14]; 
W = walking.
Timeline for recruitment and measurement Figure 2
Timeline for recruitment and measurement. Rehab = eight week pulmonary rehabilitation program; ME = maintenance 
exercise.
Rehab
Baseline
05 8 2
Real Time (months)
14
ME Group
Control Group
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tive to changes following pulmonary rehabilitation
[19,20]. The SGRQ is a self-administered questionnaire
consisting of 50 items. It will be scored from 0 – 100 with
zero indicating the best health and 100 the worst. The
questionnaire will be explained to the participants. They
will be asked to complete it to the best of their ability and
to ask for help if they have difficulty understanding the
questions.
b) Hospital Anxiety and Depression Scale (HADS) [21].
The HADS has been found to be a reliable instrument for
detecting states of depression and anxiety in hospital
medical outpatient clinics [21].
3. Lung function will be measured by:
a) Spirometry. This will be performed in accordance with
American Thoracic Society standards [22]. Forced expira-
tory volume in one second (FEV1) and forced vital capac-
ity (FVC) will be measured using a mass flow sensor
(Sensormedics Vmax 20 Pulmonary Spirometry Instru-
ment; Sensormedics Corporation, Yorba Linda, Califor-
nia, USA). The spirometer will be calibrated immediately
before each test using a three litre-calibrating syringe. The
highest value for FEV1 and FVC after three reproducible
trials will be recorded and compared to predicted normal
values [23].
b) Lung Volumes. These will be performed in accordance
with American Thoracic Society standards [24] using a
body plethysmograph (Sensormedics V6200 Autobox
Body Plethysmograph; Sensormedics Corporation, Yorba
Linda, California, USA). The plethysmograph pressure
transducer and the mouth pressure transducer will be cal-
ibrated by an automatic internal 50 ml calibration syringe
prior to testing. Total lung capacity (TLC) will be deter-
mined by summating the best inspiratory capacity (IC)
with the mean functional residual capacity (FRC) from
three acceptable tests. Residual volume (RV) will be deter-
mined by subtracting the best vital capacity (VC) from the
calculated TLC value [25]. Results will be compared to
predicted normal values for lung volumes [26].
Statistical analysis
For all outcome measures, the mean difference between
the ME group and the control group in the change from
baseline to 12 months will be determined and the signifi-
cance of these mean differences will be tested by repeated
measures ANOVA. Significance will be set at p < 0.05.
Intention to treat analysis will be used.
Power calculation
The sample size calculation is based on functional walk-
ing capacity as this is the major outcome of the study.
Redelmeier and colleagues [27] have reported that in
COPD participants, following pulmonary rehabilitation,
the minimal clinically important difference is 54 metres.
Using this value as the difference in walking distance to be
detected between the two groups and taking an effect size
of 0.7, it was estimated that the sample size required to
achieve an 80% power for a 2-sided test at 5% alpha
would be 32 subjects per group. To allow for 15% attri-
tion, 38 subjects will be recruited in each group.
Discussion
The primary aim of the study is to determine if a once a
week supervised, hospital-based exercise plus a home
exercise program will maintain functional exercise capac-
ity and quality of life in COPD subjects compared to
standard care of unsupervised home exercise, twelve
months following the completion of pulmonary rehabili-
tation. We hypothesize that exercise capacity and quality
of life will be better maintained in the ME group com-
pared to the control group.
Pulmonary rehabilitation programs consisting of exercise
and education have been shown to improve functional
exercise capacity and quality of life [28]. Benefits appear
to be maintained up to nine months following pulmo-
nary rehabilitation [6,7] and then begin to decline by
twelve months [9]. According to the Survey of Pulmonary
Rehabilitation Programs in Australia, following a pulmo-
nary rehabilitation program patients are given advice on
home exercise but very few are offered any further form of
supervised exercise training [29]. It is important to evalu-
ate if improvements gained from a pulmonary rehabilita-
tion program are able to be maintained in the longer term.
There is little scientific information on the relative merit
of a supervised, hospital-based exercise program com-
pared to an unsupervised home exercise program in sus-
taining the benefits of an intensive eight-week pulmonary
rehabilitation program in the longer term. Such informa-
tion is crucial as the goal of pulmonary rehabilitation
must be to both maximise and sustain benefits. If greater
adherence to an exercise program occurs by supervision,
the benefits of a pulmonary rehabilitation program are
more likely to be maintained.
This study may have a significant impact on the delivery
of health care to people with COPD. If it is shown that
supervised maintenance exercise programs ensure the
benefits of pulmonary rehabilitation are retained, in
terms of exercise capacity and quality of life, then such
programs should be routinely instituted.
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